Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 3
2021 3
2022 1
2023 1
2024 5
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning.
Fudman DI, McConnell RA, Ha C, Singh S. Fudman DI, et al. Clin Gastroenterol Hepatol. 2025 Feb;23(3):454-468. doi: 10.1016/j.cgh.2024.06.050. Epub 2024 Aug 13. Clin Gastroenterol Hepatol. 2025. PMID: 39147217 Free PMC article. Review.
These include the oral small molecule drugs Janus kinase inhibitors (including upadacitinib, approved for Crohn's disease and ulcerative colitis [UC], and tofacitinib, approved for UC) and sphingosphine 1-phosphate receptor modulators (ozanimod and etrasimod, both a …
These include the oral small molecule drugs Janus kinase inhibitors (including upadacitinib, approved for Crohn's disease and ulcerat …
Recommendations for the Use of Disease-Modifying Antirheumatic Drugs in Pregnancy and Reproductive Health for Patients With Rheumatic Disease: A Scoping Review.
Chin A, Terrett A, Kwon M, Whittle S, Hill C. Chin A, et al. Arthritis Care Res (Hoboken). 2025 Oct;77(10):1273-1281. doi: 10.1002/acr.25558. Epub 2025 Jun 16. Arthritis Care Res (Hoboken). 2025. PMID: 40256995 Free PMC article.
OBJECTIVE: Autoimmune rheumatic diseases commonly affect individuals of childbearing age, with historically increased adverse pregnancy outcomes in this group. The advent of disease-modifying antirheumatic drugs (DMARDs) has fostered more suitable conditions for pregnan …
OBJECTIVE: Autoimmune rheumatic diseases commonly affect individuals of childbearing age, with historically increased adverse pregnancy …
Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBase.
Abolhassani N, Noseda R, Dao K, Girardin FR, Bedussi F, Ceschi A, Panchaud A, Winterfeld U. Abolhassani N, et al. Clin Transl Sci. 2025 Dec;18(12):e70429. doi: 10.1111/cts.70429. Clin Transl Sci. 2025. PMID: 41305879 Free PMC article.
This study analyzed VigiBase, the World Health Organization global pharmacovigilance database of individual case safety reports (ICSRs), to assess signals of disproportionate reporting (SDRs) for pregnancy-related adverse drug reactions (ADRs) reported with systemic JAKIs, …
This study analyzed VigiBase, the World Health Organization global pharmacovigilance database of individual case safety reports (ICSRs), to …
Drugs for psoriatic arthritis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Dec 30;61(1588):203-210. Med Lett Drugs Ther. 2019. PMID: 31999665 Review. No abstract available.
Risankizumab (Skyrizi) for ulcerative colitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2024 Nov 11;66(1715):182-184. doi: 10.58347/tml.2024.1715d. Med Lett Drugs Ther. 2024. PMID: 39509158 No abstract available.
Mirikizumab (Omvoh) for ulcerative colitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2024 Mar 18;66(1698):46-47. doi: 10.58347/tml.2024.1698c. Med Lett Drugs Ther. 2024. PMID: 38466213 No abstract available.
Drugs for rheumatoid arthritis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Nov 15;63(1637):177-184. Med Lett Drugs Ther. 2021. PMID: 35085210 No abstract available.
Drugs for atopic dermatitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jun 15;62(1600):89-96. Med Lett Drugs Ther. 2020. PMID: 32555122 No abstract available.
Guselkumab (Tremfya) for ulcerative colitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2025 Mar 17;67(1724):46-48. doi: 10.58347/tml.2025.1724d. Med Lett Drugs Ther. 2025. PMID: 40053377 No abstract available.
JAK Inhibitors: Prospects in Connective Tissue Diseases.
You H, Xu D, Zhao J, Li J, Wang Q, Tian X, Li M, Zeng X. You H, et al. Clin Rev Allergy Immunol. 2020 Dec;59(3):334-351. doi: 10.1007/s12016-020-08786-6. Clin Rev Allergy Immunol. 2020. PMID: 32222877 Review.
We also discuss the efficacy of the first- and second-generation JAK inhibitors (tofacitinib, baricitinib, ruxolitinib, peficitinib, filgotinib, upadacitinib, solcitinib, itacitinib, decernotinib, R333, and pf-06651600) for CTDs including RA, systemic lupus erythema …
We also discuss the efficacy of the first- and second-generation JAK inhibitors (tofacitinib, baricitinib, ruxolitinib, peficitinib, …
21 results